Literature DB >> 3948628

Colonic motility and gastric emptying in patients with irritable bowel syndrome. Effect of pretreatment with octylonium bromide.

F Narducci, G Bassotti, M T Granata, M A Pelli, M Gaburri, R Palumbo, A Morelli.   

Abstract

This study was undertaken to evaluate (1) the colonic response to eating for a prolonged time in healthy subjects and patients with the irritable bowel syndrome (IBS); (2) the effect of octylonium bromide, a new smooth muscle relaxant acting by interfering with calcium ion mobilization, on the postprandial colonic motility; and (3) whether chronic gastric stasis could be responsible for both the dyspeptic symptoms often complained of by IBS patients and the faulty colonic response to eating. The colonic response to a 1000-kcal mixed meal in ten healthy subjects was characterized by two transient (from 0 to 60 and from 120 to 150 min postprandially, respectively) increases in colonic motor activity; ten IBS patients showed a continuous postprandial increase in colonic motor activity that was not terminated 180 min after eating. Treatment of IBS patients with octylonium bromide (80 mg, qid, per os) for 5-7 days reduced their colonic response to eating to a very short increase in colonic motor activity limited to the first 30 min. Finally, gastric emptying was not different in the two groups.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3948628     DOI: 10.1007/bf01318114

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

Review 1.  Are anticholinergics of use in the irritable colon syndrome?

Authors:  K J Ivey
Journal:  Gastroenterology       Date:  1975-05       Impact factor: 22.682

2.  INTESTINAL MOTILITY IN MAN. 3. MECHANISMS OF CONSTIPATION AND DIARRHEA WITH PARTICULAR REFERENCE TO THE IRRITABLE COLON SYNDROME.

Authors:  A G WANGEL; D J DELLER
Journal:  Gastroenterology       Date:  1965-01       Impact factor: 22.682

3.  The irritable bowel syndrome. Part I: clinical spectrum.

Authors:  J F Fielding
Journal:  Clin Gastroenterol       Date:  1977-09

4.  Effect of cholecystokinin on colonic motility and symptoms in patients with the irritable-bowel syndrome.

Authors:  R F Harvey; A E Read
Journal:  Lancet       Date:  1973-01-06       Impact factor: 79.321

Review 5.  Colonic myoelectric activity in the irritable bowel syndrome.

Authors:  W J Snape; G M Carlson; S Cohen
Journal:  Gastroenterology       Date:  1976-03       Impact factor: 22.682

6.  Is there a myoelectrical abnormality in the irritable colon syndrome?

Authors:  I Taylor; C Darby; P Hammond; P Basu
Journal:  Gut       Date:  1978-05       Impact factor: 23.059

7.  Metoclopramide therapy in patients with delayed gastric emptying: a randomized, double-blind study.

Authors:  M S Perkel; C Moore; T Hersh; E D Davidson
Journal:  Dig Dis Sci       Date:  1979-09       Impact factor: 3.199

8.  Electrogastrographic study of patients with unexplained nausea, bloating, and vomiting.

Authors:  C H You; K Y Lee; W Y Chey; R Menguy
Journal:  Gastroenterology       Date:  1980-08       Impact factor: 22.682

9.  Colonic motor and myoelectrical activity: a comparative study of normal subjects, psychoneurotic patients, and patients with irritable bowel syndrome.

Authors:  P Latimer; S Sarna; D Campbell; M Latimer; W Waterfall; E E Daniel
Journal:  Gastroenterology       Date:  1981-05       Impact factor: 22.682

10.  Use of the peripheral dopamine antagonist, domperidone, in the management of gastro-intestinal symptoms in patients with irritable bowel syndrome.

Authors:  R Milo
Journal:  Curr Med Res Opin       Date:  1980       Impact factor: 2.580

View more
  32 in total

Review 1.  Meditation over medication for irritable bowel syndrome? On exercise and alternative treatments for irritable bowel syndrome.

Authors:  Fredrick Asare; Stine Störsrud; Magnus Simrén
Journal:  Curr Gastroenterol Rep       Date:  2012-08

2.  Reduction by cimetropium bromide of the colonic motor response to eating in patients with the irritable bowel syndrome.

Authors:  G A Lanfranchi; G Bazzocchi; M Campieri; C Brignola; F Fois; B P Imbimbo
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  The menstrual cycle affects rectal sensitivity in patients with irritable bowel syndrome but not healthy volunteers.

Authors:  L A Houghton; R Lea; N Jackson; P J Whorwell
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 4.  Intestinal motility in irritable bowel syndrome: is IBS a motility disorder? Part 1. Definition of IBS and colonic motility.

Authors:  D P McKee; E M Quigley
Journal:  Dig Dis Sci       Date:  1993-10       Impact factor: 3.199

5.  Asian motility studies in irritable bowel syndrome.

Authors:  Oh Young Lee
Journal:  J Neurogastroenterol Motil       Date:  2010-04-27       Impact factor: 4.924

6.  Effect of oral nicardipine on anorectal function in normal human volunteers and patients with irritable bowel syndrome.

Authors:  W M Sun; C A Edwards; A Prior; S S Rao; N W Read
Journal:  Dig Dis Sci       Date:  1990-07       Impact factor: 3.199

Review 7.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

8.  Effect of meal ingestion on ileocolonic and colonic transit in health and irritable bowel syndrome.

Authors:  Annemie Deiteren; Michael Camilleri; Duane Burton; Sanna McKinzie; Archana Rao; Alan R Zinsmeister
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

Review 9.  Drug treatment of the irritable bowel syndrome.

Authors:  P L Pattee; W G Thompson
Journal:  Drugs       Date:  1992-08       Impact factor: 9.546

10.  Altered esophageal pain threshold in irritable bowel syndrome.

Authors:  M Costantini; G C Sturniolo; G Zaninotto; R D'Incà; R Polo; R Naccarato; E Ancona
Journal:  Dig Dis Sci       Date:  1993-02       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.